Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study

NCT02083874 is registered in ClinicalTrials.gov with The University of New South Wales as lead sponsor.

NCT NCT02083874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02083874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study
Lead sponsor
The University of New South Wales
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2014
Completion date
December 31, 2014
Enrollment
5 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use disorder